Products

What will AGI do for Anastrozole?

This classification denotes a non-steroidal aromatase inhibitor with the molecular formula C17H19N5, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 2Z07MYW1AZ, chemically known as 1,3-benzenediacetonitrile, alpha,alpha,alpha,alpha-tetramethyl-5-(1h-1,2,4-triazol-1-ylmethyl)- but more generally known as anastrozole, which bears US NIH Compound Identifier 2187. European Medicines Agency schedules Anastrozole in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05502MIG. The term ANASTROZOLE is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 9, No. 3, 1995, List 35). World Health Organization schedules anastrozole in its Anatomical Therapeutic Chemical (ATC) Classification. ANASTROZOLE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations, for tariff and trade purposes, schedule anastrozole under HS 29339990 and SITC 51577. As of Q4 2014, ANASTROZOLE remains US FDA's Preferred Term for this commodity. Anastrozole bears US NLM identifiers UMLS ID C0290883 and NCI Concept Code C1607. SMILES: N1(NCNC1)CC1CC(C(C)(C)C#N)CC(C(C)(C)C#N)C1.